Log in

NASDAQ:TRHCTabula Rasa HealthCare Stock Price, Forecast & News

$57.05
+2.83 (+5.22 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$54.54
Now: $57.05
$58.12
50-Day Range
$52.71
MA: $57.13
$63.46
52-Week Range
$33.04
Now: $57.05
$69.72
Volume659,140 shs
Average Volume318,805 shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.15
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software applications also comprise RxCompanion, a medication therapy management software platform for the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting for PACE organizations and small health plans. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2018, it served 224 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, and healthcare organizations for managing the medication-related needs of their patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Read More
Tabula Rasa HealthCare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.54 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.71 million
Cash Flow$1.88 per share
Book Value$8.36 per share

Profitability

Net Income$-32,440,000.00

Miscellaneous

Employees1,286
Market Cap$1.31 billion
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

How has Tabula Rasa HealthCare's stock been impacted by COVID-19 (Coronavirus)?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRHC stock has increased by 24.3% and is now trading at $57.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Tabula Rasa HealthCare.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Tabula Rasa HealthCare.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its quarterly earnings results on Thursday, May, 7th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.24. The business earned $72.80 million during the quarter, compared to the consensus estimate of $71.76 million. Tabula Rasa HealthCare had a negative return on equity of 3.01% and a negative net margin of 12.10%. Tabula Rasa HealthCare's revenue for the quarter was up 19.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.10 EPS. View Tabula Rasa HealthCare's earnings history.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its second quarter 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $76-81 million, compared to the consensus revenue estimate of $84.66 million.

What price target have analysts set for TRHC?

10 equities research analysts have issued 12 month price targets for Tabula Rasa HealthCare's stock. Their forecasts range from $50.00 to $84.00. On average, they expect Tabula Rasa HealthCare's share price to reach $71.50 in the next year. This suggests a possible upside of 25.3% from the stock's current price. View analysts' price targets for Tabula Rasa HealthCare.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

News stories about TRHC stock have been trending neutral recently, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tabula Rasa HealthCare earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the near future. View the latest news about Tabula Rasa HealthCare.

Are investors shorting Tabula Rasa HealthCare?

Tabula Rasa HealthCare saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 5,820,000 shares, an increase of 5.4% from the May 31st total of 5,520,000 shares. Based on an average daily volume of 356,200 shares, the days-to-cover ratio is presently 16.3 days. Approximately 27.8% of the company's stock are short sold. View Tabula Rasa HealthCare's Current Options Chain.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Canopy Growth (CGC), Netflix (NFLX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM), Boeing (BA), GW Pharmaceuticals PLC- (GWPH) and Intel (INTC).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $57.05.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.31 billion and generates $284.71 million in revenue each year. The company earns $-32,440,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Tabula Rasa HealthCare employs 1,286 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.